Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
BATM Advanced Communications's 10-Year RORE % for the quarter that ended in Dec. 2025 was 82.86%.
LSE:BVC's 10-Year RORE % is ranked better than 95.57% of 429
companies
in the Medical Devices & Instruments industry
Industry Median: 0.6
vs LSE:BVC: 82.86
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
BATM Advanced Communications 10-Year RORE % Related Terms
BATM Advanced Communications 10-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:BVC vs ISRG, BDX, MDLN: 10-Year RORE % Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications 10-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 10-year before.
BATM Advanced Communications (LSE:BVC) has a 10-Year RORE % of 82.86 as of Dec. 2025. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on BATM Advanced Communications and its competitors. According to the industry distribution chart, BATM Advanced Communications ranks #19 out of 429 companies in the Medical Devices & Instruments industry, placing it in the top 4.4%.
Is BATM Advanced Communications' 10-Year RORE % too high?
BATM Advanced Communications' current 10-Year RORE % is 82.86. The Medical Devices & Instruments industry median 10-Year RORE % is 0.60. BATM Advanced Communications' value of 82.86 is 13710% above this industry median. Based on the distribution chart, BATM Advanced Communications ranks #19 out of 429 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BATM Advanced Communications has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' 10-Year RORE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #19 out of 429 companies for 10-Year RORE %. This places BATM Advanced Communications in the top 4% of its industry — outperforming the majority of peers. The industry median 10-Year RORE % is 0.60. BATM Advanced Communications' value of 82.86 is 13710% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Devices & Instruments company?
The median 10-Year RORE % among Medical Devices & Instruments companies is 0.60, based on 429 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BATM Advanced Communications's current 10-Year RORE % of 82.86 is 13710% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median 10-Year RORE % is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current 10-Year RORE % is 82.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (LSE:BVC) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.17, compared to a current price of £0.15 — trading 14.7% below its estimated fair value. The current 10-Year RORE % is 82.86 and 13710% above the Medical Devices & Instruments industry median of 0.60. BATM Advanced Communications' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For BATM Advanced Communications (LSE:BVC), the current 10-Year RORE % is 82.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (LSE:BVC) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.15 is trading 14.7% below its estimated GF Value™ of £0.17.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for LSE:BVC:
10-Year RORE %: 82.86
GF Value™: £0.17 vs. price of £0.15 (14.7% below fair value)
Industry Position: 13710% above the Medical Devices & Instruments median (#19 of 429)
No single metric tells the full story. See the LSE:BVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
40GF Score
Get the complete analysis for LSE:BVC
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BVC has been successfully added to your 
